Formulation and Evaluation of Fast-Dissolving Oral Films of Empagliflozin

The objective of the present study was to develop the oral fast-dissolving film of empagliflozin by using solvent Solvent-casting method. Empagliflozin is a Class III drug used for the management of type 2 diabetes mellitus. Fast-dissolving oral films of empagliflozin were prepared with different excipients and were evaluated with various evaluation parameters. FTIR analysis showed that there was no chemical reaction between the drug and the excipients. HPMC is used as a polymer, PEG acts as a plasticizer and solubility enhancer, sodium starch glycolate acts as a super disintegrant, and DMSO is mainly used as a permeability enhancer. Evaluation of oral films includes such as Weight variation, Thickness, Folding endurance, % Elongation, Tensile strength, Drug content, Assay, Disintegration time, and invitro Diffusion studies were done. The results showed the most promising results. In this formulation 4 showed good disintegration at 20 minutes and 99% drug release within 30 minutes. The stability study results showed the prepared films were stable during the stability study.

Authors

Institutions

Publication Details

Journal
Research Journal of Pharmacy and Technology
Published
2025-03-27
DOI
https://doi.org/10.52711/0974-360x.2025.00154
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formulation and Evaluation of Fast-Dissolving Oral Films of Empagliflozin

C. Rubina Reichel, Ananth Sethuraman, L Santhiya, Sarah Alexandrina J et al.
Research Journal of Pharmacy and Technology
Diabetes Treatment and Management
article

Formulation and Evaluation of Fast-Dissolving Oral Films of Empagliflozin

C. Rubina Reichel, Ananth Sethuraman, L Santhiya, Sarah Alexandrina J, Raj R Sathiya, S Shibiyaa
article en

Abstract

The objective of the present study was to develop the oral fast-dissolving film of empagliflozin by using solvent Solvent-casting method. Empagliflozin is a Class III drug used for the management of type 2 diabetes mellitus. Fast-dissolving oral films of empagliflozin were prepared with different excipients and were evaluated with various evaluation parameters. FTIR analysis showed that there was no chemical reaction between the drug and the excipients. HPMC is used as a polymer, PEG acts as a plasticizer and solubility enhancer, sodium starch glycolate acts as a super disintegrant, and DMSO is mainly used as a permeability enhancer. Evaluation of oral films includes such as Weight variation, Thickness, Folding endurance, % Elongation, Tensile strength, Drug content, Assay, Disintegration time, and invitro Diffusion studies were done. The results showed the most promising results. In this formulation 4 showed good disintegration at 20 minutes and 99% drug release within 30 minutes. The stability study results showed the prepared films were stable during the stability study.

Research Journal of Pharmacy and Technology
Sri Ramakrishna Institute of Paramedical Sciences (IN)
Openalex Percentile: Top 90%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Formulation and Evaluation of Fast-Dissolving Oral Films of Empagliflozin — C. Rubina Reichel, Ananth Sethuraman, et al. · Research Journal of Pharmacy and Technology (2025) | TGRS Research Map | TGRS